Analysis of the difference in gene expression and mutation of glioblastoma in different age groups by using the transcriptional and exome sequencing

WANG Zhi-gang LIU Wei

Acta Anatomica Sinica ›› 2019, Vol. 50 ›› Issue (1) : 8-12.

PDF(6853 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(6853 KB)
Acta Anatomica Sinica ›› 2019, Vol. 50 ›› Issue (1) : 8-12. DOI: 10.16098/j.issn.0529-1356.2019.01.002
Neurobiology

Analysis of the difference in gene expression and mutation of glioblastoma in different age groups by using the transcriptional and exome sequencing

  • WANG Zhi-gang1 LIU Wei 2*
Author information +
History +

Abstract

Objective To explore the gene expression difference of glioblastoma in different age groups through the sequencing of the transcriptome and exome. Methods Glioblastoma multiforme(GBM) data was downloaded from the Cancer Genome Atlas(TCGA), and the samples were divided into two groups. There were 78 cases in the middle and low age group not more than 60 years old, compared with the high age group of 60 years old, with a total of 76 cases. DESeq2 package was used to analyze differentially expressed genes based on gene level reads numbers. Cytoscape plug-in ClueGO was used to analyze gene function enrichment in different age groups. Results Most of the gene expression trends in the two groups were consistent between the two groups, but there were some different genes. In the middle and low age group, the differential gene was mainly related to the proliferation of neural precursor cells, while the high age group was metabolic. In the two groups, the high mutation genes were basically consistent, but the mutation rates were different. The mutation differentially genes were concentrated in the middle and low age groups. Conclusion There is a significant difference in gene expression and gene mutation between the middle and low age group and the elderly GBM group.

Key words

RNA-sequencing / Age;Glioblastoma / Exome-sequencing / Human

Cite this article

Download Citations
WANG Zhi-gang LIU Wei. Analysis of the difference in gene expression and mutation of glioblastoma in different age groups by using the transcriptional and exome sequencing[J]. Acta Anatomica Sinica. 2019, 50(1): 8-12 https://doi.org/10.16098/j.issn.0529-1356.2019.01.002

References

 [1]Young RM, Jamshidi A,Davis G,et al. Current trends in the surgical management and treatment of adult glioblastoma[J]. Ann Transl Med, 2015, 3(9): 121.
 [2]Lorimer CF, Hanna C, Saran F, et al. Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes [J]. Clin Oncol (R Coll Radiol), 2017,29(11): 739-747.
 [3]Hartmann C, Hentschel B, Wick W, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas [J]. Acta Neuropathol, 2010, 120(6): 707-718.
 [4]Nobusawa S, Watanabe T, Kleihues P, et al. DH1 mutations as molecular signature and predictive factor of secondary glioblastomas[J]. Clin Cancer Res, 2009, 15(19): 6002-6007.
 [5]Love MI, Huber W, Anders S. Anders. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol, 2014, 15(12): 550.
 [6]Filimon A, Zurac SA, Milac AL, et al. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors[J]. Melanoma Res, 2014, 24(3): 219-236.
 [7]Wang K, Chen D, Qian Z, et al. Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma[J]. Cancer Cell Int, 2017,17(117):1-12.
 [8]Tong Y, Xu Y, Scearce-Levie K, et al. COL25A1 triggers and promotes Alzheimer’s disease-like pathology in vivo[J]. Neurogenetics, 2010, 11(1): 41-52.
 [9]Zheng H, Ying H, Yan H, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation[J]. Nature, 2008, 455(7216): 1129-1133.
 [10]Han B, Cai J, Gao W, et al. Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma[J]. Cancer Lett, 2018, 419: 280-290.
 [11]Russo A, O’Bryan JP. Intersectin 1 is required for neuroblastoma tumorigenesis[J]. Oncogene, 2012, 31(46): 4828-4834.
PDF(6853 KB)

Accesses

Citation

Detail

Sections
Recommended

/